1Nordt TK, Lutzi S, Ruef J, et al.Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells[J].Thromb Haemost,2001,86.
2Malamitsi-Puehner Sarandakou A, Tziotis J, etal. Circulating anglo- genie factors during periovulatlon and the luteal phase of normal menstrual cycles[J].Fertil Steril,2004,81.
1Goto F, Goto K. Syneerstic effects of vascular endothelial factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cell with collagengel [J]. Lab Invest, 1993, 69:508.
2Houck KA, Ferrara N, et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA [J]. Mol Erdocrial,1991, 5:1806.
3Rifkin PB, Moscatellid, et al. Recent developments in the cell biology of basic fibroblast growth factor [J].J cell Blol,1989,109:1.
4Hofmann GE, Soott RTJ, Bergh PA, etal. Immunohistochemical localization of epidermal growth factor in human endomertrium,decidua and plaoenta[J]. J clin Endocrinal Metab, 1991, 73:882.
5ArakawaS, IsobeS, MoriH, etal. The effect of epidermal growth factor on progestin secretion and cyclic AMP synthesis in cultured luteal cells from pregnant rats [J]. Endocrinol, 1990, 37:479.
6Knoibl E, Neill J. The physiology of Reporoduction[M],lsted. New York: Oxford Vniversity press, 1988:489.
